Hristo Ganchev

A Phase II, Open-Label, Randomized Study to Assess the Efficacy and Safety of AZD6244 (ARRY-142886) Versus Pemetrexed in Patients with Non-small Cell Lung Cancer Who Have Failed One or Two Prior Chemotherapeutic Regimens

John D. Hainsworth, C. Cebotaru, Vladimir Kanarev et al. · Journal of Thoracic Oncology · 2010 · 160 citations · Full text

Medicine, Oncology, Pharmacology +11

Efficacy and safety of AZD6244 (ARRY-142886) as second/third-line treatment of patients (pts) with advanced non-small cell lung cancer (NSCLC)

Valentina Tzekova, C. Cebotaru, Tudor–Eliade Ciuleanu et al. · Journal of Clinical Oncology · 2008 · 27 citations

Medicine, Oncology, Pharmacology +17

O-104 XYOTAXT™ vs. gemcitabine or vinorelbine for the treatment of performance status (PS) 2 patients with chemotherapy-naïve advanced non-small cell lung cancer (NSCLC): The STELLAR 4 Phase III study

M. O’Brien, Alan Sandler, Alexander Y. Popovich et al. · Lung Cancer · 2005 · 13 citations

Medicine, Oncology, Pharmacology +12